Van ECK Associates Corp Grows Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY
MarketBeat
Van ECK Associates Corp raised its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 8.4% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 58,666 shares of the biopharmaceutical company's stock after acquiring an additional 4,529 shares
NASDAQ:ALNY